title: [Lymphatic filariasis transmission assessment survey in schools three years after stopping mass drug treatment with albendazole and ivermectin in the 7 endemic districts in Togo].
abstract: The aim of this study is to verify the level of transmission of lymphatic filariasis three years after stopping mass drug treatment in the 7 endemic districts in Togo. The survey was conducted in 2012 in Togo's 7 endemic districts grouped into four evaluation units (EU) using the WHO-recommended transmission assessment survey (TAS) protocol. Children aged 6-7 years were screened for Wuchereria bancofti antigen using the immunochromatographic card (ICT) method. A cluster sampling method was used to select eligible children in schools as the net primary-school enrolment ratio is greater than or equal to 75% in each of the four EUs. The number of children and schools to be selected in each EU, the randomization list for the selection of these children and the critical cut-off number of positive cases not to exceed were automatically generated using the Survey Sample Builder (SSB) tool, (NTD Support Center, Atlanta, Ga, USA). For confirmation, positive cases were subsequently tested for microfilaremia using nocturnal thick blood smear and for filarial antigen using Og4C3 antigen ELISA (TropBio ELISA Kit®, Townsville, Queensland, Australia). An EU is considered to have passed the test successfully (it is assumed that transmission can no longer be sustained), when the number of positive cases is below the critical cut-off number set by the SSB, which is roughly equivalent to 2% prevalence. Of the 1 706 children surveyed in Kpendjal-Tone's EU, 1 549 in Binah-Doufelgou's EU, 1 550 in Kozah's EU and the 1 575 in Amou-Haho's EU, 8 (0.46%), 1 (0.08%), 0 (0.00%) and 4 (0.25%) ICT positive cases respectively were detected. The number of positive ICT tests was well below 18, the critical cut number for each of the 4 EUs. All 13 ICT positive cases tested negative for nocturnal microfilaremia and Og4C3 ELISA. We conclude that all four EU passed the TAS with success, and the transmission of Wuchereria bancrofti is no longer likely to be sustained in the 7 endemic districts in Togo 3 years after stopping the MDA. A new TAS will be carried out in 2015, after which, if the results are still good, the country will submit a dossier to WHO for verification of the elimination of lymphatic filariasis.
authors.affiliation: Ministère de la Santé du Togo, BP 336, Lomé, Togo, monicadork@yahoo.fr.
authors.forename: A M
authors.initials: AM
authors.lastname: Dorkenoo
authors.forename: Y K
authors.initials: YK
authors.lastname: Sodahlon
authors.forename: R N
authors.initials: RN
authors.lastname: Bronzan
authors.forename: K
authors.initials: K
authors.lastname: Yakpa
authors.forename: E
authors.initials: E
authors.lastname: Sossou
authors.forename: A
authors.initials: A
authors.lastname: Ouro-Medeli
authors.forename: M
authors.initials: M
authors.lastname: Teko
authors.forename: A
authors.initials: A
authors.lastname: Seim
authors.forename: E
authors.initials: E
authors.lastname: Mathieu
mesh_terms: D015766:Albendazole / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D000871:Anthelmintics / Q000008:administration & dosage / Q000627:therapeutic use*; D000947:Antigens, Helminth / Q000097:blood; D002648:Child; D002846:Chromatography, Affinity / Q000295:instrumentation; D003430:Cross-Sectional Studies; D004605:Elephantiasis, Filarial / Q000175:diagnosis / Q000453:epidemiology* / Q000517:prevention & control / Q000635:transmission; D019353:Endemic Diseases / Q000517:prevention & control; D005260:Female; D006078:Government Programs; D006293:Health Promotion / Q000458:organization & administration; D006306:Health Surveys; D006801:Humans; D007559:Ivermectin / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008403:Mass Screening; D008842:Microfilariae / Q000302:isolation & purification; D018512:Parasitemia / Q000175:diagnosis / Q000469:parasitology; D017410:Practice Guidelines as Topic; D015397:Program Evaluation; D012494:Sampling Studies; D012572:School Health Services; D012574:Schools; D014037:Togo / Q000453:epidemiology; D014944:World Health Organization; D014958:Wuchereria bancrofti / Q000276:immunology / Q000302:isolation & purification
chemical_list: D000871:Anthelmintics; D000947:Antigens, Helminth; D007559:Ivermectin; D015766:Albendazole